CSE bulletin 2026-0903

Effective immediately, Nirvana Life Sciences Inc. has been suspended pursuant to Canadian Securities Exchange Policy 3. The suspension is considered a regulatory halt as defined in National Instrument 23-101, Trading Rules. A cease trade order has been issued by the British Columbia Securities Commission.

For more information about cease trade orders, visit the Canadian Securities Administrators cease trade order database.

Date:  Sept. 4, 2026

Symbol:  NIRV.X